HS Code 30024123 — Vaccines for human medicine (COVID-19 etc.)
Chapter 30 (Pharmaceutical Products) · Heading 3002 (Blood, antisera, vaccines, toxins, microorganisms and similar products) · Last updated: May 2026 · Source: Indian Customs (DGFT) Records
HS Code 30024123 (Vaccines for human medicine (COVID-19 etc.)) is one of India's most significant pharmaceutical export classifications under Chapter 30 of the Harmonized System. With a total trade value of $34.4M across 281 shipments, this code covers 1 distinct pharmaceutical products exported by 5 Indian manufacturers to 10 countries. The leading product under this classification is Vaccine at $34.4M, followed by .
The top importing markets include Pakistan, Nigeria, Bangladesh. The top 5 products account for 100.0% of total trade under this code. Average transaction value is $122.6K. Leading exporters include GLAXOSMITHKLINE BIOLOGICALS SA and SANOFI PASTEUR. Data sourced from Indian Customs (DGFT) shipping bill records.
Products Exported Under HS Code 30024123
1 pharmaceutical products classified under this code, ranked by trade value
| Rank | Product | Trade Value | Transactions | Avg Price | Suppliers |
|---|---|---|---|---|---|
| #1 | Vaccine | $34.4M | 281 | $7.25 | 30 |
Import Destinations — HS Code 30024123
10 countries import products classified under HS Code 30024123 from India
Indian pharmaceutical exports under HS Code 30024123 reach 10 countries worldwide. The largest importer is Pakistan ($88.1M), followed by Nigeria ($84.5M), Bangladesh ($78.1M), Kenya ($55.9M). This geographic spread reflects India's position as the world's largest supplier of generic pharmaceutical products by volume.